Navigation Links
DUSA Pharmaceuticals to Present at the Merriman Curhan Ford Investor Summit 2009
Date:11/6/2009

WILMINGTON, Mass., Nov. 6 /PRNewswire-FirstCall/ -- DUSA Pharmaceuticals, Inc.(®) (Nasdaq GM: DUSA), a dermatology company that is developing and marketing Levulan(®) Photodynamic Therapy (PDT) and other products focused on patients with common skin conditions, announced that Bob Doman, President and Chief Executive Officer, will present a corporate overview at the Merriman Curhan Ford Investor Summit 2009 on Tuesday, November 10, 2009 at 10:00 a.m. ET at the Hotel Sofitel in New York City. Interested investors can access the live audio webcast of the presentation at www.dusapharma.com. An archived version of the presentation will be available on the DUSA website for 90 days following the presentation.

About DUSA Pharmaceuticals

DUSA Pharmaceuticals, Inc.( ® )is an integrated dermatology pharmaceutical company focused primarily on the development and marketing of its Levulan(®) Photodynamic Therapy technology platform, and complementary dermatology products. Levulan( )PDT is currently approved for the treatment of Grade 1 and 2 actinic keratoses of the face and scalp. DUSA also markets other dermatology products, including ClindaReach(®). DUSA is researching Levulan PDT for the treatment of AKs and the prevention of new non-melanoma skin cancer in chronically immunosuppressed solid organ transplant recipients. DUSA is based in Wilmington, Mass. Please visit our web site at www.dusapharma.com.

SOURCE DUSA Pharmaceuticals, Inc.


'/>"/>
SOURCE DUSA Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related medicine technology :

1. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Third Quarter 2009 Financial Results on Tuesday, November 10, 2009 at 8:30 a.m. EST
2. Transcept Pharmaceuticals to Report Third Quarter 2009 Results and Host Conference Call on November 12
3. Trubion Pharmaceuticals, Inc. Reports Third Quarter and Nine Months 2009 Financial Results
4. Jazz Pharmaceuticals Announces Third Quarter 2009 Financial Results
5. Amylin Pharmaceuticals to Present at the 18th Annual Credit Suisse Healthcare Conference
6. Savient Pharmaceuticals Reports Third Quarter 2009 Financial Results
7. Peregrine Pharmaceuticals Awarded Second Broad U.S. Patent for Anti-Viral Applications of Phospholipid-Targeting Antibodies
8. Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Tuesday, November 10, 2009
9. VIA Pharmaceuticals Featured at American Heart Association Scientific Sessions 2009
10. Reportlinker Adds Gastrointestinal Pharmaceuticals: Technologies and Markets
11. Peregrine Pharmaceuticals Regains Full Compliance With Nasdaq Continued Listing Requirements

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...RNewswire-FirstCall/--HeartWareInternational,Inc.(...roflessinvasive,miniaturizedcirculatorysupporttech...failure,todayannouncedthatitisscheduledtomakeaninv...CareConferenceat8:00amESTonWednesday,December2,200...December1-2. ,, AlivewebcastoftheCompany,sprese...
(Date:11/24/2009)...rstCall/--Endologix,Inc.(Nasdaq: ELGX ),developero...ouncedtodaythatithasfiledamotiontostay,ordiscontin...ughtagainstitinOctober2009byCook,Inc.Themotionwasf...ndiana. ,, Endologixhasrequestedthatthestayrema...fice(USPTO)conductsproceedingstore-examinethetwopa...
(Date:11/24/2009)...4/PRNewswire/-- EisaiInc.andPfizerIncannouncedtod...ptedforreviewEisai,sNewDrugApplication(NDA)foronce...)tabletsforthetreatmentofmoderatetosevereAlzheimer...23mgofdonepezilHClinanextendedrelease,matrix-typet...eofthedrug.TheNDAisbasedonahead-to-headclinicalstu...
Breaking Medicine Technology:Endologix Files Motion to Discontinue Court Proceedings Related to Alleged Patent Infringement 2FDA Accepts Once Daily 23 mg Aricept(R) Extended Release NDA for Review 2FDA Accepts Once Daily 23 mg Aricept(R) Extended Release NDA for Review 3DST Systems Inc Announces Exchange Transaction Involving 4 125 25 Series A Convertible Senior Debentures 58653 1DST Systems Inc Announces Exchange Transaction Involving 4 125 25 Series A Convertible Senior Debentures 58653 2Medicago begins human clinical testing with its avian flu pandemic vaccine 14315 1Medicago begins human clinical testing with its avian flu pandemic vaccine 14315 2Prostate Cancer Study Results Published on Patients Treated With CyberKnife Radiosurgery 5145 1Prostate Cancer Study Results Published on Patients Treated With CyberKnife Radiosurgery 5145 2Prostate Cancer Study Results Published on Patients Treated With CyberKnife Radiosurgery 5145 3Prostate Cancer Study Results Published on Patients Treated With CyberKnife Radiosurgery 5145 4
(Date:11/25/2009)...wire-FirstCall/-- OnyxPharmaceuticals,Inc.(Nasdaq...estoreventsinDecember: ,, ASHBriefing ,,...rincipalinvestigatorswilldiscussdatapresentationss...tiplemyeloma,asfeaturedatthe51stAmericanSocietyofH...ns,LA.Theteleconferencewillbeginat9:00a.m.CT/10:00...
(Date:11/25/2009)...ire/--Thanksgivingmealswillbedeliveredtoapproximat...hankstoFaithInAction/VolunteerActionforAging,aprog...ANHealthPlan.Formorethan17yearstheseorganizationsh...givingmealstoseniorsinneedinLongBeach,Lakewood,Sig...es. ,, "Ourwarmholidaymealsaredeliveredtopeople...
(Date:11/25/2009)...--TheBayAreaAirQualityManagementDistrictisissuingt...lert forThursday,November26,2009whichbansburning...ndoorsandoutdoors. ,, "Cold,stillweatherwillcon...dbent,executiveofficeroftheAirDistrict."We,reaskin...sandfellowcommunitymembersthisThanksgiving,andnott...
(Date:11/25/2009)...statistically significant survival benefit from ad...eptor (ER)-positive tumors had high levels of phos...118-P), according to a brief communication publish...nal Cancer Institute . , Approximately 50% of br...nical studies have shown that ER-alpha S118-P is r...
(Date:11/25/2009)...t to draw definite conclusions, experts say, , ...n diabetic patients with blocked coronary arteries... one year whether patients undergo bypass surgery ...report. , Bypass surgery has been the standard ...ry disease. However, less invasive approaches such...
Breaking Medicine News(10 mins):Health News:Onyx Pharmaceuticals Announces December 2009 Investor Events 2Health News:SCAN Employees and Community Volunteers to Help Deliver One Thousand Thanksgiving Meals to Homebound Seniors 2Health News:Winter Spare the Air Alert in Effect for Thursday, November 26, 2009 2Health News:Stenting May Equal Bypass for Diabetic Heart Patients 2Health News:Stenting May Equal Bypass for Diabetic Heart Patients 3
...with market stress, he said , , NEW YORK, March 1...market, psychiatrist and trading coach Ari Kiev, M...eenwich Roundtable, a non-profit research and educ...ders and portfolio managers and works with promine...
...t for brain-wasting disorders such as Creutzfeldt-...News) -- The drug quinacrine doesn,t prolong survi...such as Creutzfeldt-Jakob disease (CJD), British r...t malaria and some forms of arthritis -- has been ...
...With Photo , To mark this year,s No Smoking Da...ead to win a GBP2,000 investment from TV Dragon Du...nge, the school children faced their toughest,chal..., won with her proposal to,support parents who wan...
...tack: prevention has improved, mortality rates are...t in Circulation from the Framingham Heart Study... incidence in 9824 men and women over four decades...dy found that over the past 40 years rates of AMI ...
...rk of healthcare employment Web sites offers recru... needs., , Englewood, CO ...oyment climbs, many healthcare fields are still st...,000) and in hospitals (7,000). Employment gains i...
... dangers to overall health, the North Carolina Den...nts to not give up routine dental examinations and... , "Routine dental examinations can preclude many...na ranks 34th in the country in terms of the numb...
Other Medicine News:Health News:Psychiatrist and Trading Coach Dr. Ari Kiev Addresses Greenwich Roundtable 2Health News:"I'm In" - Duncan Bannatyne Judges "Switch Ash for Cash" Schools Competition 2Health News:"I'm In" - Duncan Bannatyne Judges "Switch Ash for Cash" Schools Competition 3Health News:"I'm In" - Duncan Bannatyne Judges "Switch Ash for Cash" Schools Competition 4Health News:Explaining trends in heart attack 2Health News:Healthcare Industry Continues to Post Gains in a Down Economy 2Health News:N.C. Dental Society Urges North Carolinians to Not Forego Dental Care 2
Inorganic Phosphorus Color Reagent
Amylase (EPS-G7, kinetics)
Amylase Reagent
Calcium Reagent Set
Medicine Products: